Qure.ai recently closed a $65 million Series D funding round. This round was led by Lightspeed and 360 ONE Asset, with participation from Merck Global Health Innovation Fund and Kae …
The United States Food and Drug Administration (USFDA) has granted breakthrough device designation to Qure.ai’s AI-powered Tuberculosis (TB) solution, qSpot-TB, a company statement informed. The qSpot-TB Artificial Intelligence (AI) is …
The United States Food and Drug Administration (USFDA) has approved Qure.ai’s Artificial Intelligence (AI)-enabled solution for chest X-ray. The solution based on qXR-LN uses AI to identify and localise lung …
We are a dedicated team of passionate entrepreneurs, storytellers and innovators. We understand the drive, ambition and challenges founders face, because we are founders ‘ourselves.’
Follow Linkedin Newsletter to receive latest news & events updates. Let’s stay updated!
@The Founder Media 2023
